SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 25.54+1.4%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bluegreen who wrote (7184)9/5/1998 8:49:00 AM
From: Robert K.   of 17367
 
To further drive home the point of cytokine effects of BPI>>>>>>>>>
>>http://www.med.uni-muenchen.de/immuno/ziegler/MonoMac/MM6oth019.html

>Ask yourselves this. How many other sepsis drugs failed that tried to
affect just one cytokine or whatever. TNF, IL-1 etc....
You know anti-TNF monoclonals are finding use NOW.
And they only target TNF. Hmmmmmmmm.
Cascade, cocktail, Hmmmmmm.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext